- Available:In stock842
- Availability date:2020-07-30
- Dosage form:Tablets
- In stock:842 Items
The active ingredient in Altabor tablets is the substance of the dry extract of sulfur alder and sticky alder, which contains a mixture of ellagotanins of mono- and oligomeric origin based on phenolic acids (ellagic, gallic, dilactone, valonic acid). these polyphenolic compounds have pronounced antiviral properties against influenza virus, vesicular stomatitis and herpes simplex. the mechanism of antiviral action of altabor is to induce the synthesis of interferon, inhibition of the activity of the neuraminidase of the influenza virus, as well as the virus-specific thymidine kinase of the herpes virus, which leads to the cessation of the synthesis of viral dna. additional pharmacological properties of altabor are a wide spectrum of antibacterial activity relative to gram-positive (staphylococcus aureus, bacillus subtilis) and gram-negative (escherichia coli, pseudomonas aeruginosa, proteus mirabilis, klebsiella) microorganisms. pronounced antioxidant, anti-inflammatory, membrane-stabilizing and analgesic effects enhance the pharmacotherapeutic properties of the drug in the treatment of ARVI and influenza, which are often complicated by a bacterial infection and are accompanied by inflammation and pain.
Pharmacokinetics Not studied.
Altabor is used for the prevention and treatment of influenza, ARVI.
For the prevention of altabor, use 2 tablets 3 times a day. slowly dissolve the drug in the mouth. the duration of prevention is 7 days.
For the treatment of Altabor, use 2 tablets 4 times a day. The drug slowly dissolve in the mouth. The duration of treatment is 7 days.
The use of altabor is contraindicated in case of hypersensitivity to the components of the drug, tannin-containing drugs.
When using Altabor, nausea, softness of the palate and allergic reactions, including rash, itching, flushing of the skin, urticaria, may occur.
The drug can not be prescribed in combination with almagel, bismuth, iron, and other drugs that contain metal ions.
The drug contains sorbitol, so patients with rare hereditary fructose intolerance should not use it.
Use during pregnancy and lactation. There are no clinical data on the effectiveness and safety of the drug during pregnancy, therefore Altabor is contraindicated in this category of patients. If it is necessary to use the drug in women breastfeeding, breastfeeding should be discontinued.
Children. There are no clinical data on the efficacy and safety of the drug in children, therefore, Altabor should not be prescribed to children under the age of 14 years.
The ability to influence the reaction rate when driving vehicles and working with other mechanisms. No data.
Due to the polyphenolic base, the altabor tablets form complexes with metal salts (such as aluminum, bismuth, iron), which leads to a loss of the pharmacological activity of the drug.
With increased sensitivity to the components of the drug, an overdose can cause skin allergic reactions.
Treatment. It is necessary to stop taking the drug. It is recommended to induce vomiting or gastric lavage. Symptomatic treatment is indicated.
In the original packaging at a temperature not exceeding 25 ° C.